This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
09/01/15 - 10:35:22 AM ET (BATS BZX Real-time Price)
Div Yield: --
XOMA Day's Range
XOMA 52 Week Range
XOMA Business Summary
XOMA Corporation discovers and develops antibody-based therapeutics in the United States, Europe, and the Asia Pacific.View XOMA key stats
XOMA Corp - XOMA - EQUITY
Reviewed By: TheStreet Ratings on .
Report Summary: TheStreet Ratings team rates XOMA Corp as a
Sell with a ratings score of E+.
Report Snippet: We rate XOMA CORP (XOMA) a SELL. This is based on a variety of negative investment measures, which should drive this stock to significantly underperform the majority of stocks that we rate. The company's weaknesses can be seen in multiple areas, such as its unimpressive growth in net income and generally disappointing historical performance in the stock itself.